Navigation Links
KV Pharmaceutical Company Reduces Workforce
Date:2/9/2009

Layoffs result from recent challenges, effort to reduce costs

ST. LOUIS, Feb. 9 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) announced today it is in the process of reducing its workforce by approximately 700 jobs. The action is part of an overall cost-cutting program as the company works toward resuming full operation. The company has encountered a number of substantial challenges over the past months, including a voluntary suspension of product manufacturing and shipment, as well as voluntary recalls of its products.

"KV Pharmaceutical plans to emerge from these challenges on a solid foundation of a smaller, more focused organization and the return to providing excellent products to our customers," said David Van Vliet, interim President and CEO. "The need to reduce our employee base is regrettable and one of the most difficult parts of our program to resume manufacturing and shipping product."

The KV workforce reduction includes a combination of terminations and layoffs. The company expects to recall some employees when production and shipment of approved products resume.

To resume product shipments as quickly as possible, the company is currently working with Lachman Consulting, a third-party consulting group, to enhance KV's current Good Manufacturing Practice (cGMP) processes and quality systems. KV continues to work in full cooperation with the U.S. Food and Drug Administration (FDA).

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology distinguished products through ETHEX Corporation, a subsidiary that competes with branded products, and Ther-Rx Corporation, the company's b
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... New York, NY (PRWEB) September 30, 2014 ... an award-winning managed IT solutions firm based in ... contract to deploy CRA’s Manage360° solution to transform, ... NYC-based Nonprofit Organization (NPO) who is a leading ... become healthy, productive, and self sufficient. The ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Bibliomotion ... Leader: Redefining Leadership for the Complex Social Age by ... 30, 2014). , In the book, the authors apply their ... through which to view the conversations, actions, and behaviors that ... networked world. Click here to read a review ...
(Date:9/30/2014)... 30, 2014 RBS Reputation Management is reported ... ‘Remove Your Name’. , The service name may surprise ... giving the service this odd name, a management professional said, ... in this name. We have named the service ‘Remove Your ... to get rid of all those posts which light their ...
(Date:9/30/2014)... Hollywood, Florida (PRWEB) September 30, 2014 A ... newest techniques and seeks out upcoming medical breakthroughs in spine ... outcomes he has seen in his patients in which he ... The design and its components are state-of-the art and mimic ... that the Mobi-C has also been proven to be an ...
(Date:9/30/2014)... 2014 Seniors Guide will take part ... race beginning in Raleigh, to support Alzheimer’s North Carolina ... and care. , Associate Publisher of Seniors Guide Magazine, ... senior resource for the Raleigh-Durham-Chapel Hill areas of North ... will be helping their team, “Eye of the Tiger”, ...
Breaking Medicine News(10 mins):Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 2Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 3
... UNC Lineberger Comprehensive Cancer Center, offers hope for people with ... disease characterized by excessive production of red blood cells. ... of stroke, and in some cases the disease is a ... cases are associated with a mutation in the JAK2 gene, ...
... 2011 Three senior Hebrew University of Jerusalem faculty ... Innovation Awards for their multi-year research efforts which have ... Prof. Haim Rabinowitch of the Robert H. Smith Faculty ... of Jerusalem, has been named winner of the first ...
... Patients with amyotrophic lateral sclerosis (ALS) could lose brain ... to make decisions about their care. Physicians need a ... without the need for extensive neuropsychological tests. Penn ... that identifies frontotemporal disease (FTD) deficits in judgment and ...
... June 22 (HealthDay News) -- Heart damage caused by heavy ... a new study. Researchers assessed the heart health of ... drug rehabilitation program 48 hours after they last used cocaine. ... years and consumed about 5.5 grams of cocaine per day. ...
... Reporter , TUESDAY, June 21 (HealthDay News) -- High doses ... have a downside. A new meta-analysis finds that intensive ... risk of being diagnosed with type 2 diabetes compared with ... still revealed a lower incidence of heart attacks, stroke and ...
... HealthDay Reporter , TUESDAY, June 21 (HealthDay News) -- ... want to ask if there are any unlocked guns in ... American homes with kids contain unlocked, loaded guns, experts say, ... That,s why the Center to Prevent Youth Violence (PAX) ...
Cached Medicine News:Health News:Three senior Hebrew University faculty members receive Kaye Awards for innovations 2Health News:Brief exam diagnoses cognitive impairment in ALS patients 2Health News:Cocaine-Related Heart Damage May Be 'Silent' 2Health News:High-Dose Statins May Increase Diabetes Risk 2Health News:High-Dose Statins May Increase Diabetes Risk 3Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 2Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 3Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 4
(Date:9/29/2014)... SAN DIEGO , 29 septembre ... désignée Daiichi Sankyo) (TSE : 4568) et Ambit Biosciences ... d,un accord de fusion définitif en vertu duquel ... actions ordinaires en circulation d,Ambit Biosciences à 15 ... d,une offre publique d,achat qui sera suivie d,une ...
(Date:9/29/2014)...  Bob Pack, who lost his two young children ... Medical Association to immediately cease airing a television ad ... Mercury News called "shamelessly deceptive" and of which the ... believe about the measure is wrong." ... that doctors check California,s existing ...
(Date:9/29/2014)... Sept. 29, 2014  Volcano Corporation (Nasdaq: ... improving patient and economic outcomes on a global ... coronary and peripheral visualization, physiology diagnostics and therapies, ... Board of Directors from Engaged Capital, LLC.  The ... Volcano welcomes the perspectives of its ...
Breaking Medicine Technology:Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3
... studied the treatment of pregnant women with hepatitis B virus ... study concluded that both the mothers benefited from treatment and ... weeks postbirth. The study presenter and co-investigator Calvin ... as hepatitis B is difficult to eradicate and currently there ...
... POINT, Calif., Nov. 1, 2010 The Global ... organization that aims to raise awareness about the ... 7,000 Bracelets for Hope™ campaign. The 7,000 Bracelets ... to an estimated 7,000 different chronic, life-threatening and ...
Cached Medicine Technology:Telbivudine Given to Mothers With Hepatitis B Reduces Infection Rate in Infants 2Telbivudine Given to Mothers With Hepatitis B Reduces Infection Rate in Infants 37,000 Bracelets For Hope™ - A Rare Disease Awareness Campaign 27,000 Bracelets For Hope™ - A Rare Disease Awareness Campaign 3
... Aplicare's Saturated Swabsticks are packaged ... Each 4 inch Swabstick is saturated ... solution. Each package is terminally sterilized, ... the patient. It acts as a ...
... Antiseptic Antibacterial that does not ... 30 seconds, destroys over 99% ... for cleansing of minor wounds, ... disinfection of personal utensils and ...
... professional degerming, pre-op and post-op procedures. ... quaternary and substituted phenolic active ingredients ... and surfactants. Unprecedented efficacy on all ... 30 seconds. Techni-Care represents a new ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
Medicine Products: